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1. Introduction
Colonoscopy is a common procedure in medical practice for a variety of gastrointestinal in‐
dications. It is widely used in the United Stated, especially since 2001, when Medicare ex‐
panded its coverage for screening for colorectal cancer to include colonoscopy. An estimated
14.2 million colonoscopies were performed in 2002 in the United States, with screening indi‐
cations representing half of cases [1]. Although generally considered a safe procedure, com‐
plications of colonoscopy as an invasive procedure should be noted. Complications vary
from minor symptoms such as minor abdominal discomfort to more serious complications
such as colonic perforation, cardiopulmonary arrest, or even death (Table). Although most
studies have focused on serious complications, the less serious complications are important
because they are more frequent than reported and may have an impact on willingness of pa‐
tients and their peers to undergo future colonoscopy. Colonoscopy complications are cate‐
gorized as immediate; occurring during the procedure or before discharge from endoscopy
unit, or delayed; occurring within 30 days of the procedure. We will present in this chapter
these potential complications in detail.
2. Complications of colonoscopy
2.1. Death
Death has been reported as a complication of colonoscopy in 30 days from the procedure. Its rate
varies between studies from 0 to 83.3 per 10,000 colonoscopies [2-15]. In 3 studies with a total of
16,747 patients of mean age 59 years, there was no single death within 30 days of colonoscopy
[6-8]. In a study in outpatient colonoscopy in the Medicare population by using Surveillance,
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Epidemiology and End Result (SEER) database, there were 53 deaths within 30 days of 53,220
patients (9.9 deaths per 10,000 colonoscopies) [2]. The main focus in that study was not the death
rate but the serious gastrointestinal and cardiopulmonary events which increased with ad‐
vance age, history of stroke, congestive heart failure (CHF), chronic obstructive pulmonary dis‐
ease (COPD), atrial fibrillation, diabetes mellitus (DM), and use of polypectomy.
Most deaths are not related directly to the procedure itself, rather to severe underlying comor‐
bidities such as CHF, severe underlying coronary artery disease, COPD, cirrhosis, stroke, and
pneumonia [3,4,11]. In a study of 9,223 patients from the UK, there were 10 deaths within 30
days of procedure (10.8 deaths per 10,000 colonoscopies); however, four cases were considered
to be due to severe comorbidities rather than the procedure itself [4]. The mean age of study pop‐
ulation was 58 years (range: 16-95 years) with 14.1% were 75 years or older. The reported causes
of death were pneumonia, CHF, myocardial infarction, stroke and cirrhosis [4]. In a study of
13,580 patients, one single death occurred during colonoscopy in patient with massive GI bleed‐
ing (0.7 deaths per 10,000 colonoscopies) [5]. One single death occurred in 26,162 colonoscopies
in another study done by Tran (0.38 deaths per 10,000 colonoscopies) which occurred in a pa‐
tient with underlying coronary artery disease and COPD who developed perforation and died
postoperatively from myocardiac ischemia [11].
Polypectomy has been shown to be an independent risk factor for death. In a study from
Germany with 82,416 colonoscopies, death rate was 0.1 per 10,000 colonoscopies, which was
7-fold higher if polypectomy was performed [9].
However, the mortality rate was as high as 83.3 deaths per 10,000 colonoscopies in an Aus‐
tralian study of 23,508 outpatients with 196 deaths within 30 days of the procedure, al‐
though only 3 deaths were attributed to the colonoscopy itself (1.2 deaths per 10,000
colonoscopies) [13]. In a 2010 review of complications of colonoscopy from large studies,
there were 128 deaths attributed to colonoscopy among 371,099 colonoscopies (3.4 deaths
per 10,000 colonoscopies) [14,15].
2.2. Cardiopulmonary complications
Cardiopulmonary complications may be related to the preparation, conscious sedation, or
the procedure itself. It might occur during or immediately after the procedure, including
respiratory depression, hypoxia, dyspnea, hypotension, hypertension, bradycardia, tachy‐
cardia, vasovagal reactions, cardiac arrhythmias, and chest pain. Most of these events occur
at endoscopy unit; however, they may occur days after the procedure. Fortunately, most of
these complications are self-limited and resolve with minor interventions. In a study of
21,375 patients by Ko,et al. there were 160 cases of respiratory depression (74.8 per 10,000
colonoscopies) [3]. Also in this study, there were 105 cases of immediate cardiovascular
complications (49.1 per 10,000 colonoscopies), with the vast majority being hypotension (65
cases; 30.4 per 10,000 colonoscopies) and bradycardia (32 cases; 14.9 per 10,000 colonoscop‐
ies). Vasovagal reaction occurred in 14 cases (6.5 per 10,000 colonoscopies), tachycardia in 2
cases (0.9 per 10,000 colonoscopies), and hypertension in one case (0.4 per 10,000 colonos‐
copies). One hundred and thirty four cases required supplemental oxygen (62.6 per 10,000
colonoscopies), 48 cases intravenous fluids (22.4 per 10,000 colonoscopies), 29 cases nalox‐
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one (13.5 per 10,000 colonoscopies), 20 cases atropine (9.3 per 10,000 colonoscopies), and 16
cases required flumazenil (7.4 per 10,000 colonoscopies).
Complications Rate of complications (cases per 10,000 colonoscopies)
Death 0-83.3
Cardiopulmonary events
Hypotension 0.2-48
Hypertension 0.4-2.1
Vasovagal reaction 6.5-19
Arrhythmia 1.9-102
Bradycardia 0.3-28
Tachycardia 0.7-0.9
Chest pain 0.7-45.2
Pulmonary edema 0.2-57.3
Transient hypoxia 0.8-23
Respiratory depression 0.7-74.8
Perforation 0.4-19
Bleeding 8.5-63.8
Postpolypectomy electrocoagulation syndrome 0.3-9.3
Gas explosion Case reports in the literature
Infections
Bacterial endocarditis Case reports in the literature
Acute diverticulitis 0.8-8.4
Pneumonia 0.4-0.9
Per-perineum infections 0.9-3.1
Minor GI symptoms 133.1-4100
Cerebrovascular events 0.8-6.5
Table 1. Rate of complications of colonoscopy
In a retrospective study of 174,255 colonoscopies in the Clinical Outcomes Research Initia‐
tive (CORI) database, there were 1995 unplanned cardiopulmonary events (114.4 per 10,000
colonoscopies) which were significantly higher than in EGD [16]. Hypotension occurred in
867 cases (48 per 10,000 colonoscopies), bradycardia in 507 cases (28 per 10,000 colonoscop‐
ies), vasovagal reaction in 341 cases (19 per 10,000 colonoscopies), transient hypoxia in 410
(23 per 10,000 colonoscopies), low oxygen saturation in 128 (7 per 10,000 colonoscopies),
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prolonged hypoxia in 14 cases ( 0.7 per 10,000 colonoscopies), hypertension in 38 cases(2.1
per 10,000 colonoscopies), arrhythmia in 34 cases (1.9 per 10,000 colonoscopies ), chest pain
in 14 cases (0.7 per 10,000 colonoscopies), respiratory distress in 13 cases(0.7 per 10,000 colo‐
noscopies), tachycardia in 13 cases (0.7 per 10,000 colonoscopies), pulmonary edema in 4
case (0.2 per 10,000 colonoscopies), wheezing in 3 cases (0.1 per 10,000 colonoscopies), and
tracheal compression in one case (0.05 per 10,000 colonoscopies) [16]. The risk factors were
advanced age, high American Society of Anesthesiologists (ASA) class, inpatient status, trainee
participation, and non-university and veterans hospitals [16].
Higher doses of meperidine required for colonoscopy were associated with higher cardio‐
pulmonary events, whereas there was an inverse association with doses of fentanyl and
midazolam in the study by Sharma [16]. The association between lower dose of benzodiaze‐
pines use in endoscopy and cardiopulmonary events was suggested first in a small earlier
study [17]. Droperidol has been used effectively for conscious sedation in difficult endos‐
copy, but has notable potential complications including QT prolongation and torsade de
pointes. In one study, the use of droperidol for conscious sedation was not associated with
increased cardiopulmonary events [16].
In a study of 53,220 outpatient colonoscopies in the Medicare population using the SEER data‐
base and diagnosis coding system, there were total of 1030 cardiovascular events (193.5 per
10,000 colonoscopies) with arrhythmias compromised more than half events which were statis‐
tically significant than matched group [2]. There were 241 cases of acute coronary syndrome
and 115 cases of cardiopulmonary arrest in 30 days which was not statistically significant from
matched group. Advanced age, polypectomy during procedure, CHF, atrial fibrillation, DM,
COPD, and stroke were the independent risk factors for adverse cardiovascular events [2]. It has
been shown that life expectancy decreases significantly for patients with 3 or more chronic con‐
ditions at the time of colon cancer diagnosis, illustrating importance of considering chronic co‐
morbidities in elderly patients when evaluating for screening colonoscopy [18].
In a study of 82,416 colonoscopies from Germany, there were 12 cases of cardiopulmonary com‐
plications during the procedure (1.4 per 10,000 colonoscopies); oxygen desaturation in 7 cases
(0.8 per 10,000 colonoscopies) which were treated by oxygen supplement or flumazenil, brady‐
cardia in 3 cases (0.3 per 10,000 colonoscopies) which were treated by atropine, and hypotension
in 2 cases (0.2 per 10,000 colonoscopies) which were treated by intravenous fluids [9]. Most of
these complications occurred in patients received the combination of benzodiazepines with
opioids, whereas no cardiopulmonary event was recorded when use propofol [9].
Appropriate evaluation for anesthesia risk, identifying high-risk patients, consulting other
specialties based on their comorbidities, and appropriate monitoring before, during and af‐
ter the procedure may reduce the rate of cardiopulmonary complications.
2.3. Perforation
Colonic perforation may occur due to therapeutic endoscopic interventions, barotrauma due
to air insufflation during colonoscopy, mechanical forces against colon wall, or during ma‐
neuvering of the scope. Persistent abdominal pain after colonoscopy and abdominal disten‐
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sion may present initially, however a late presentation with abdominal abscess is possible.
Although plain X-Rays may reveal sub-diaphragmatic free air, CT scan is more sensitive to
detect any free air in the abdomen and pelvis which should be considered in cases with high
suspicion of perforation. The rate of perforation varies between studies from 0.4-19 cases per
10,000 colonoscopies.
There were 4 cases of perforation in a study of 82,416 colonoscopies without poypectomy
(0.4 per 10,000 colonoscopies), but it was 14 times higher if polypectomy was performed
during the procedure (6.3 per 10,000 colonoscopies) [9]. Although the majority of polypecto‐
my was done in the left colon, half of the perforations after polypectomy occurred in the
right colon [9].
In another study of 21,375 patients, there were 4 cases of perforation (1.8 per 10,000 colonos‐
copies); all of them female, two occurred without biopsy or polypectomy [3]. The risk of se‐
rious complications including perforation, GI bleeding, post-polypectomy syndrome and
diverticulitis (all combined) increased with pre-procedure warfarin use and performance of
polypectomy with cautery [3].
In a population-based cohort study of 67,632 colonoscopies performed in persons between
50-75 years of age, there were 37 cases of perforation (5.4 per 10,000 colonoscopies); 57%
were detected on the day of procedure, 92% within 2 days, and all within 5 days [19]. In 62%
of these cases snare polypectomy was performed. The median length of stay was 6 days
(0-18), comparing to 2 days (0-15) when GI bleeding occurred as a complication of colono‐
scopy. Although 68% of them underwent surgery; one of them died after hemicolectomy,
32% were treated conservatively without mortality [19].
In a study of 53,220 Medicare beneficiaries (age 66-95 years) who had outpatient colonosco‐
py, there were 33 cases of perforation (6.2 per 10,000 colonoscopies) with 21 cases of them
(63.6%) underwent polypectomy [2]. The independent risk factors for serious gastrointesti‐
nal complications including perforation and GI bleeding were advanced age, DM, CHF,
COPD, atrial fibrillation, stroke, and performing polypectomy [2].
A study from the UK with 9,223 pediatric and adult patients, there were 12 cases of per‐
foration (13 per 10,000 colonoscopies);  half  of  them diagnosed at  the time of  colonosco‐
py,  another two before discharge from the unit,  and the rest  presented 1,  7,  16,  and 24
days  after  the  procedure  [4].  Four  of  the  perforations  followed biopsy  or  polypectomy
from 1841  patients  underwent  any  kind of  therapeutic  or  diagnostic  interventions  (21.7
per 10,000 colonoscopies).
There were 15 cases of perforation in a study of 16,318 patients (9.1 per 10,000 colonoscop‐
ies); 12 cases either had biopsy or polypectomy (80%) [12]. The rate of serious complications
(including perforation, bleeding, diverticulitis, postpolypectomy syndrome; all combined)
after removal of polyps larger than 10 mm was significantly higher than in those with re‐
moval of smaller polyps. All perforations were detected in 7 days of the procedure. The risk
factors were increasing age, female gender, and polypectomy.
In a large retrospective cohort study of 277,434 patients, 228 cases of perforation occurred
(8.2 per 10,000 colonoscopies) [20]. The predictors for perforation were advanced age, ob‐
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struction as an indication for the colonoscopy, significant comorbidities, and performance of
invasive interventions during the procedure.
In an Australian study of 23,508 patients over 10 years, there were 23 perforations (9.7 per
10,000 colonoscopies), 78% occurred with a mucosal intervention (hot snare polypectomy)
[13]. The rectosigmoid was the most common site of perforation, followed by the cecum.
Surgical intervention was performed in 83%, and one death occurred. Median time to diag‐
nosis was 1 day (0-5 days) with length of hospitalization stay 8 days (3-26 days).
The sigmoid colon is probably susceptible to perforation due to the mechanical forces on the
sigmoid during colonoscopy, the common occurrence of diverticular disease in sigmoid, and
frequency of colonic polyps in this area. The relatively thin-walled right colon is more pre‐
disposed to barotrauma and thermal injury during polypectomy.
Twenty cases of perforation occurred in a study of 10,486 patients (19 per 10,000 colonos‐
copies);  65% in sigmoid colon and 25% in cecum [10].  Comparing to  flexible  sigmoido‐
scopy, there were only two cases of perforation in 49,501 sigmoidoscopies (0.4 per 10,000
sigmoidoscopies).  Although most  of  perforations (91%) detected in 2 days of  colonosco‐
py,  9% presented after  2  weeks with abdominal  abscess.  All  patients  except  an 87 year
old who died underwent surgery with 37% required only simple closure without any re‐
section. The average length of stay was 7.7 ± 2.8 days. Female gender was an independ‐
ent risk factor for perforation.  Transmural electrocautery burns (36%),  mechanical  injury
(32%) from the tip and shaft of scope, and barotrauma (5%) were the main mechanisms
of perforation [10]. Defects caused by diagnostic intervention tend to be larger than those
caused by electrocautery injury.
Perforations occurring more often in female which may be due to frequency of pelvic sur‐
gery in females, diverticular disease, or the higher likelihood of looping because of longer
colonic lengths [3,10,21].
In a large study of 116,000 patients underwent colonoscopy at ambulatory centers, 37 cases
of perforation occurred (3.1 per 10,000 colonoscopies); most of them female (73%), 49% had
diverticular disease, 54% had history of pelvic or colon surgery [21]. Sigmoid colon was the
most common site of perforation (62%) then ascending colon (16%). The time to diagnosis
ranged from immediate (29 patients) to 3 days (8 patients). Surgery was performed in 95%,
and conservative treatment in the rest. No mortality occurred.
Although surgery consultation should be obtained in any case of perforation, conservative
treatment with bowel rest, hydration, and intravenous antibiotics has been increasingly
used in selected cases [5,19,21]. There are also case reports revealing successful closure with
endoscopic clips to repair perforations [22].
In a study of 97,091 outpatient colonoscopies, the rate of perforation was 8.5 per 10,000 colo‐
noscopies. The risk factors for colonoscopy-related perforation were older age, increased co‐
morbidity score, polypectomy, and low-volume endoscopists (when perforation combined
with bleeding) [23]. However, this finding was different from a study by Wexner which
showed neither an absolute number of prior colonoscopies, nor any ongoing annual experi‐
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ence affected the serious complication rates [5]. Also Ko and colleagues did not find any re‐
lation between complication rate and annual colonoscopy volume, trainee participation, or
practice setting [3].
Preventative measures to avoid perforation have been suggested, including decreasing the
risk of barotrauma by minimal air insufflation, minimizing loop formation, encouraging the
use of cold techniques in the removal of small polyps, and injection of saline into the submu‐
cosa for removal of flat or sessile polyps [14,15].
2.4. Bleeding
Colonic bleeding is the most common serious complication following colonoscopy. Al‐
though it may occur after diagnostic procedure, it mostly follows therapeutic colonoscopy
from either biopsy or polypectomy, and can be immediate or delayed up to several weeks
after colonoscopy.
In a population-based study of 97,091 patients aged 50-75 years, bleeding rate within 30
days was 16.4 per 10,000 outpatient colonoscopies. The independent risk factors for colo‐
noscopy-related  bleeding  were  older  age,  male  gender,  polypectomy,  and  low-volume
endoscopists [23].
In another population-based, matched cohort study of 53,220 Medicare patients of age 66-95
years, there were 340 cases of GI bleeding (63.8 per 10,000 outpatient colonoscopies) which
was significantly higher than matched group [2]. The risk of bleeding was 4 times higher
when polypectomy was performed (21 bleeding episodes per 10,000 colonoscopies without
polypectomy compared to 87 per 10,000 colonoscopies with polypectomy). Older age, histo‐
ry of COPD, CHF, atrial fibrillation, and stroke were other independent risk factors for seri‐
ous GI events (bleeding and perforation) [2].
In a study of 23,508 patients, 49 cases of GI bleeding occurred (20.8 cases per 10,000 colonos‐
copies); all cases associated with biopsy or polypectomy, median time to presentation with
bleeding was 6 days (0-14 days), and length of stay was 2 days (1-18 days) [13]. No death
was contributed to bleeding, none required surgery, colonoscopic interventions was per‐
formed in 4 cases (8%), and blood transfusion in 7 cases (14%) [13].
Use of aspirin or any other non-steroidal anti-inflammatory drugs (NSAIDs) alone does not
increase risk of postpolypectomy bleeding. Thus, the American Society for Gastrointestinal
Endoscopy (ASGE) recommends continuing aspirin and NSAIDs if one of them is used
alone and if its use is necessary [24-27]. However, there is some evidence that combination
of aspirin with one or more NSAIDs may increase the risk of bleeding after polypectomy;
therefore discontinuation of NSIADs 2-3 days before polypectomy is recommended in pa‐
tients receiving aspirin [24-27]. Also, use of clopidogrel alone does not increase risk of post‐
polypectomy bleeding; however, concomitant use of aspirin or any other NSAIDs increases
the risk of bleeding [3,24,25,28].
Pre-procedure warfarin use increases risk of bleeding after colonoscopy, thus discontinua‐
tion of warfarin is recommended 3-5 days before colonoscopy, however bridging with hepa‐
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rin or its equivalents is important in high risk patients for thrombosis such as a mechanical
cardiac valve [3,14,24,25,29].
A prospective cohort study of 21,375 patients of age over 40 years using CORI database,
there were 34 cases of GI bleeding requiring hospitalization within 30 days following colo‐
noscopy (15.9 per 10,000 colonoscopies), and half of them required blood transfusion [3].
Pre-procedure warfarin use and snare polypectomy with cautery had an increased risk of
serious complications. Risk increased even further if more than one polypectomy with cau‐
tery was done.
Size of resected polyps, number of polyps removed, and histology type of polyps have been
reported as increased risk factors for postpolypectomy bleeding [3,28-30].
Management of bleeding detected during colonoscopy can be performed with endoscopic
approach; however, delayed bleeding is managed conservatively with bowel rest, intrave‐
nous hydration and blood transfusion if required. Repeat colonoscopy is often required for
hemostasis. Angiographic embolization and surgery are preserved for selected cases with
massive, severe, persistent bleeding [3,15,31]. However, many cases of bleeding are minimal
and self-limited.
Twenty one cases of bleeding occurred within 30 days in a study of 24,509 patients aged 16
years or older who underwent lower GI endoscopy including colonoscopy and sigmoido‐
scopy (8.5 per 10,000 colonoscopies) [31]. Seven of them required blood transfusion, 15 re‐
quired repeat endoscopy and 2 required laparotomy. The average time to present was 6
days (0-16 days).
Some measures suggested to decrease the bleeding rate after polypectomy including use of
cold snare instead of hot biopsy forceps, prophylactic use of mechanical methods such as
clips and detachable snare loops, and injection of epinephrine into submucosa of large ses‐
sile polyps [14,15,32].
2.5. Postpolypectomy electrocoagulation syndrome
Postpolypectomy  syndrome  results  from  electrocoagulation  injury  to  the  bowel  wall
when electrocautery  is  used which causes  transmural  burn and focal  peritoneal  inflam‐
mation without radiologic evidence of frank colonic perforation. It is characterized by se‐
vere localized abdominal pain, fever, localized peritonitis signs, and leukocytosis without
any radiologic evidence of perforation. Patients usually present within 1-5 days after co‐
lonoscopy performed with electrocautery polypectomy. The rate of this syndrome varies
from 0.3 to 9.3 cases per 10,000 colonoscopies, depending on differences in defining this
syndrome [12,14,15,31].
In  a  study  of  16,318  patients  aged  40  years  or  older,  6  cases  of  postpolypectomy  syn‐
drome  occurred  in  11,083  colonoscopies  with  biopsy  performed  (5.4  cases  per  10,000
colonoscopies)  [12].
The recognition of postpolypectomy syndrome is of importance because it does not require
surgical treatment as frank perforation. The diagnosis can be made by CT scan in the appro‐
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priate clinical scenario which shows focal thickening of the colonic wall at a polypectomy
site with peri-colonic fat stranding [33]. The treatment is conservative, including bowel rest,
intravenous hydration and antibiotics [15,33]. Outpatient management with oral antibiotics
also has been reported [12].
Postpolypectomy syndrome occurs more often with resection of large sessile polyps when
prolonged, high thermal energy is applied. Therefore saline injection into the sub mucosa of
large sessile polyps before polypectomy may decrease the rate of this complication [33].
2.6. Gas explosion
Gas explosion during colonoscopy is rare but has potential life-threatening consequences
including death.  It  triggers  when three  elements  are  available  in  the  colon lumen:  high
level  of  combustible gases such as hydrogen and methane produced by fermentation of
non-absorbable carbohydrates by colonic flora,  high level of  oxygen, and electrical  ener‐
gy  that  produces  heat  such  as  electrocautery  and  argon  plasma  coagulation  [15,34,35].
High levels  of  hydrogen and methane are  produced in  the  colonic  lumen by fermenta‐
tion of non-absorbable carbohydrates (lactulose,  mannitol)  or incompletely absorbed car‐
bohydrates (lactose, fructose, sorbitol) by the colonic bacteria, or the presence of stool in
the colonic lumen due to poor cleansing preparation or using enema for sigmoidoscopy
[15,34-38].  In  a  review in  2007  searching  from 1952-2006,  there  were  only  ten  cases  re‐
ported  in  the  literature  including  one  case  from  the  reviewer  [15,34].  Most  of  cases
caused  colonic  perforation  with  one  death.  Bowel  preparation  using  manitol  which  is
rarely used in current practice for colonic cleansing, using cleansing solutions containing
sorbitol, or using enemas containing no fermentable agents were participating factors for
gas  explosions  [34].  Newer  bowel  preparation  solutions  such  as  polyethylene  glycol
(PEG) and sodium phosphate are safer for electrocautery and argon plasma coagulation
by not producing inflammable levels of hydrogen and methane. Using argon plasma co‐
agulation  during  sigmoidoscopy  following  enemas  carries  risk  for  gas  explosion  which
should only be performed after complete colonic preparation with new solutions not con‐
taining manitol or sorbitol. It has been suggested using frequent air insufflation and suc‐
tion before performing these procedures,  using carbon dioxide during colonoscopy,  and
using oral antibiotics to decrease combustible levels of hydrogen and methane in colonic
lumen when using manitol or sorbitol [15,35-37].
2.7. Acute diverticulitis
Acute diverticulitis is another potential complication of colonoscopy. It  is caused by mi‐
croscopic perforation of the colon which may develops following colonoscopy in persons
with  pre-existing  diverticulosis  due to  barotrauma or  mechanical  forces  from the  endo‐
scope. Acute diverticulitis following colonoscopy has been poorly investigated and infre‐
quently  mentioned in  studies  reporting other  complications  of  colonoscopy.  The rate  of
diverticulitis  as  a  complication  of  colonoscopy  has  been  reported  from  0.8  to  8.4  cases
per 10,000 colonoscopies [3,12,14,31].
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In a study of 16,318 patients aged 40 years or older,  there were 6 cases of  diverticulitis
within 30 days of colonoscopy (3.6 cases per 10,000 colonoscopies); 2 cases required sur‐
gery and the rest were treated conservatively, 5 of them developed in colonoscopy with
biopsy performed [12].
In another study of 21,375 patients aged 40 or older, there were 18 cases of diverticulitis within
30 days of colonoscopy (8.4 per 10,000 colonoscopies) with majority did not require hospitaliza‐
tion [3]. The risk factors for serious GI complications (perforation, bleeding, postpolypectomy
syndrome, and diverticulitis) were prior warfarin use, and polypectomy with cautery; howev‐
er, these risks were not individualized to each complication but all combined [3].
In third study of 24,509 outpatients who underwent colonoscopy or sigmoidoscopy, there 2 cas‐
es of acute diverticulitis within 30 days of colonoscopy (0.8 per 10,000 colonoscopies) [31].
2.8. Infection
Transient bacteremia can occur during and after colonoscopy due to bacterial translocation
of normal colonic flora to blood stream. Then these bacteria may potentially adhere to dis‐
tant tissue such as endocardium and artificial devices, however clinical infections are rare.
Transient bacteremia associated with colonoscopy occurs in average of 4.4% ranging from
0-25% [24,39,40]. However, harmless transient bacteremia occurs in some daily activities
such as tooth brushing in 23-68% [24,39,41]. These isolated bacteria during colonoscopy are
generally believed to have little potential to cause endocarditis. The most common isolated
organisms are normal skin flora which could contamination during blood draw [24,42,43].
Despite more than 14 million colonoscopies are performed each year in the United States,
there have been only 15 reported cases of infectious endocarditis with temporal relation
with colonoscopy; thus, potential side effects of prophylactic antibiotic outweigh their possi‐
ble benefit of preventing endocarditis [24,39,44]. Due to the lack of convincing evidence of
risk of endocarditis, both the American Heart Association (AHA) and ASGE have revised
their recommendations against prophylactic antibiotics before colonoscopy [39,44].
In cirrhotic patients with or without ascites in the absence of acute GI bleeding who undergo
colonoscopy, the risk of bacteremia is low. In a study of 58 cirrhotic patients who underwent
colonoscopy, there were 4 cases of positive blood culture (6.9%) without in development of
infections [42].
Patients on peritoneal dialysis may be at risk for infectious complications after colonoscopy.
There are several reported cases of peritonitis in patients on peritoneal dialysis after colono‐
scopy especially postpolypectomy [45,46]. The International Society for Peritoneal Dialysis
(ISPD) in 2005 recommended prophylactic antibiotics and emptying the peritoneal fluid be‐
fore colonoscopy; however 2010 ISPD recommendations did not address these prevention
strategies [47,48].
Infections in prosthetic joints has been reported after colonoscopy, however the risk is too
low which led ASGE to recommend against using prophylactic antibiotics for patients who
have prosthetic orthopedic devices undergoing colonoscopy [39,49,50].
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Acute appendicitis following colonoscopy has been described in the literature. In a review in
2008, there were only 12 cases reported in literature from 1985 to 2007 [51]. Pre-existing sub‐
clinical disease of the appendix, barotrauma, impaction of stool into the appendix, direct in‐
tubation of appendiceal lumen, and focal edema in appendiceal orifice from trauma leading
to obstruction are proposed mechanisms of acute appendicitis after colonoscopy [51].
Pneumonia within 30 days of colonoscopy has been reported. In a study of 21,375 patients,
there were 2 cases of pneumonia within 30 days of colonoscopy (0.9 cases per 10.000 colo‐
noscopies) [3]. Another study of 24,509 patients, 1 case of pneumonia developed in 30 days
of colonoscopy (0.4 per 10,000 colonoscopies) [31]. The mechanism is mostly aspiration sec‐
ondary to sedation and anesthesia more than related to the procedure itself.
Local infections in perineum including perianal abscess and Fournier’s gangrene have been
described following colonoscopy. In a study of 3,196 patients, there was one case of Fourni‐
er’s gangrene occurring 2 days after colonoscopy (3.1 cases per 10,000 colonoscopies) [6]. In
another study of 21,375 patients, 2 cases of perirectal abscess occurred during 30 days of co‐
lonoscopy (0.9 per 10,000 colonoscopies) [3]. The mechanism is local mechanical trauma to
the perineum area during the procedure.
2.9. Abdominal pain and other minor GI symptoms
Although abdominal pain can be the symptom of above mentioned serious complications,
less severe abdominal discomfort is more common following colonoscopy. The mechanism
is multifactorial including mechanical trauma, barotrauma, gaseous distension secondary to
air insufflation. It is usually self-limited and rarely required hospitalization; however it is of
importance because it may affect the adherence for any future surveillance colonoscopy. In a
study by Ko et al. there were 5 cases of abdominal pain requiring hospitalization (2.3 cases
per 10,000 colonoscopies) [3]. In a study of 53,220 patients, abdominal pain occurred in 176
patients (33 cases per 10,000 colonoscopies), paralytic ileus in 172 patients (32.3 cases per
10,000 colonoscopies), and nausea and vomiting in 361 patients (67.8 cases per 10,000 colo‐
noscopies) which all were significantly higher compared to the matched group [2]. The risk
of these symptoms was higher if polypectomy was performed.
Minor adverse events that defined as any health problem that patient experienced in 30 days
of colonoscopy not requiring a hospital visit were reported in telephone interview in 466 pa‐
tients of a study of 1,528 patients (41%) with majority were GI symptoms including 195 cas‐
es of abdominal discomfort, 64 cases of self-limited rectal bleeding which lasted 1-3 days, 6
cases of nausea, and 62 cases of change in bowel habits including diarrhea (n=20), constipa‐
tion (n=11), flatulence (n=8), fecal incontinence(n=3), fecal urgency (n=3), and mucus dis‐
charge (n=2) [8]. There were also 2 cases of severe abdominal pain that required
hospitalization. Among the patients who were not retired and reported minor adverse
events, 26.1% missed one extra day of work after the day of procedure, 5.9% missed 2 days
beside the day of colonoscopy, and 8.8% missed 3 days or more [8].
Minor complications occurred in 162 subjects (34%) in a prospective cohort study by Ko et
al. most commonly bloating (25%) and abdominal pain (11%) [52]. Minor adverse events
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were more common in women, and when the procedure lasted 20 minutes or longer. Colon‐
ic preparation was reported by patients as the most difficult part of the procedure in 77%.
Most patients (94%) missed 2 or fewer days from normal activities for the preparation, pro‐
cedure itself, or recovery [52].
These minor adverse events have 3 aspects of effect; they are inconvenience to patients, have
indirect cost by missing work, and can affect the willingness of patients to undergo any fur‐
ther colonoscopy in future if need it.
Reducing looping of  the  endoscope and minimizing air  insufflation may decrease some
of these symptoms [53].  It  has been also suggested using carbon dioxide,  which is  rap‐
idly absorbed and excreted through lungs,  as  an insufflating gas for  colonoscopy to re‐
duce  these  symptoms  [54,55].  Also  water  immersion  technique  instead  of  air
insufflation has been proposed to reduce these minor events especially in cases of  min‐
imal  sedation [56]  (Leung 2010).
2.10. Miscellaneous
The most serious miscellaneous complications have reported within 30 days of colonoscopy
are cerebrovascular accident (CVA), transient ischemic attack (TIA), and pulmonary embo‐
lisms which most likely related to temporary cessation of anticoagulation agents and anti‐
platelet medications peri-procedure period [3,6-8,13].
Stroke or TIA occurred within 30 days of colonoscopy in 3.3 cases per 10,000 colonoscopies
in study of 21,375 patients [3]. In a study of 1,528 patients, there was one case of TIA, and
one case of pulmonary embolism within 30 days of colonoscopy (6.5 cases of each per 10,000
colonoscopies) [8]. A third study of 23,508 patients, there were two cases of TIA and reversi‐
ble ischemic neurologic deficit lasting 24 hours and 72 hours, occurring in recovery period
following the procedure (0.8 per 10,000 colonoscopies) [13]. However, these rates are compa‐
rable with the expected annual adjusted rate of stroke in general population [3].
Splenic hematoma and rupture, intramural hematoma, subcutaneous emphysema in the ab‐
sence of frank colonic perforation, tearing of mesenteric vessels with intra-abdominal bleeding,
thrombosis in carotid-subclavian artery bypass graft, thrombophlebitis in the intravenous site,
intestinal obstruction, and ischemic and chemical colitis secondary to glutaraldehyde or air in‐
sufflation have been reported following colonoscopy in literature [3,14,15,23,31,57,58].
2.11. Polyp and cancer miss rates
Although it is not a true complication of colonoscopy, missing colorectal polyps and cancer
is of importance because it affects patient’s safety, malpractice, and determining the surveil‐
lance interval for repeat colonoscopy. In a study of 235 patients, the miss rate for advanced
adenomas which defined as polyps ≥10 mm with or without a villous component or high-
grade dysplasia was 2.5% and 3.3% for patients who had complete colonoscopy and satisfac‐
tory colon preparation on second and third repeat colonoscopy, respectively [59]. There was
no cancer missed [59].
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In another prospective study with repeated colonoscopy performed within 2 months of first
colonoscopy, the miss rate of colorectal polyps was 21.2%; however, as number of polyps
found on first colonoscopy increased, the miss rate increased to reach 77.8% when 4 polyps
found [60]. The miss rate decreased inversely with polyps’ size from 23.9% with polyps of
1-4 mm to 10% for polyps of size ≥10 mm [60].
However,  the  overall  miss  rate  for  adenomas  was  as  high  as  24%  in  a  study  of  183
patients  who  underwent  2  consecutive  colonoscopies  on  the  same  day.  The  miss  rate
increased  with  number  of  polyps  detected  on  first  colonoscopy,  inversely  with  polyps’
size,  and right  colon [61].
In a systematic review of 6 studies of a total of 465 patients, the pooled polyps miss rate was
22% which increased inversely with polyps’ size to reach 26% for polyps of 1-5 mm [62].
Also withdrawal time of endoscope is an important factor for detecting adenomas with min‐
imal recommended time of 6 minutes. The detection rates for adenomas ≥ 10 mm were only
2.6% for endoscopists with mean withdrawal time less than 6 minutes, compared to 6.4% for
those with withdrawal time greater than 6 minutes [63]. Therefore, polyp miss rate increases
with short withdrawal time.
3. Complications associated with specific colonoscopic interventions
3.1. Colonoscopic tattooing
Colonic tattooing is an injection of permanent dye into the submucosal layer of colon wall
that adjacent to the lesion for easier future localization either for surgical resection or colo‐
noscopic follow-up. Although three studies with a total of 264 patients who underwent colo‐
noscopic tattooing reported no fever, abdominal pain, or any major complications [64-66], a
systematic review of 447 patients with colonoscopic tattooing described 5 cases of complica‐
tions with only one was an overt clinical complication (22.3 per 10,000 tattooing) [67].
It  has  been  reported  cases  of  intramural  hematoma,  colonic  abscess,  rectus  muscle  ab‐
scess  following  colonoscopic  tattooing,  bowel  obstruction,  retroperitoneal  colonic  perfo‐
ration  due  to  localized  necrosis,  adhesion  ileus,  and  spread  of  the  dye  following
colonoscopic  tattooing [68-75].
3.2. Colonic balloon dilation
Colonic dilation has been used as a non-surgical treatment for benign strictures that associ‐
ated with Crohn’s disease and those at surgical anastomoses [76].
In  a  systematic  review  in  2007  of  13  studies  with  347  patients  with  Crohn’s  disease
with  colonic  strictures  who  underwent  695  sessions  of  colonic  dilation,  there  were  14
cases  of  major  complications  (201.4  cases  per  10,000  colonic  dilations);  13  cases  being
bowel  perforation (92.8%) [77].
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Two prospective studies with a total of 42 patients with benign colorectal anastomotic steno‐
sis, not associated with Crohn’s disease, who underwent 81 sessions of colonic dilation re‐
ported no procedure-related complications [78,79].
3.3. Colonic stent placement
Self-expandable metal stents (SEMS) have been used in the management of colorectal obstruc‐
tion as a bridge to surgery or as a palliative treatment especially malignant obstruction. In a
pooled analysis of 54 studies with 1,198 patients who underwent colonic stent placement, the
major complications related to stent placement included stent migration (11.81%), reobstruc‐
tion (7.34%), perforation (3.76%), and mortality (0.58%) [80]. The risk factors for stent migration
which may occur proximally or distally were using covered stent, laser treatment, dilation prior
stent insertion, and the use of chemotherapy and radiotherapy. The causes for reobstruction
were tumor ingrowth (73.2%), fecal impaction, mucosal prolapse, stent migration, tumor over‐
growth, and peritoneal seeding. The reobstruction was significantly higher in uncovered stents.
The perforation was related to stent wires, balloon dilation, guide wires, or related to laser re‐
canalization prior stent placement. The death was related to colonic perforation and its conse‐
quences in majority of cases [80].
In another systematic review of 1,785 patients with 1,845 stent placements, colonic reob‐
struction in 12%, migration of the stent occurred in 11%, perforation in 4.5%. Other reported
complications of stent placement included GI bleeding, anal pain, abdominal pain, and ten‐
esmus which were relatively rare and generally well tolerated by patients [81]. It is not rec‐
ommended to perform dilation around the time of stent placement due to increased
perforation risk [76,80].
Despite  of  the  early  termination  of  3  randomized  controlled  trials  comparing  SEMS  to
surgery  because  of  high  rate  of  complications  in  SEMS groups,  a  recent  systematic  re‐
view  in  2012  with  234  patients  including  these  3  trials  showed  that  the  clinical  perfo‐
ration  rate  was  6  9%  and  the  silent  perforation  rate  14%.  There  was  no  difference
between  SEMS  arm  and  emergent  surgery  in  primary  anastomosis,  permanent  stoma,
in-hospital  mortality,  anastomotic  leak,  30-day  reoperation  and  surgical-site  infection
rates  [82-85].
3.4. Colonic decompression tube placements
Transanal endoscopic decompression tube placement has been used in acute colorectal ob‐
struction or pseudo-obstruction before surgery or stenting.
In 5 series consisting of 153 patients with acute colonic obstruction treated with transanal
decompression tube placement, two cases of bowel perforation occurred (1.3%) [86-90].
In a series of 50 patients with acute colonic pseudo-obstruction who underwent 54 decom‐
pression tube placements, one case of bowel perforation occurred (2%), and overall in-hospi‐
tal mortality was 30% reflecting severe underlying comorbidities [91].
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3.5. Percutaneous endoscopic colostomy
Percutaneous endoscopic colostomy (PEC) is considered a minimally invasive endoscopic
procedure that has been used as an alternative modality to surgery in poor surgical candi‐
dates who have recurrent sigmoid volvulus, recurrent colonic pseudo-obstruction, neuro‐
genic bowel or severe slow-transit constipation [76,92-94].
The complications of PEC that has been reported are fecal peritonitis (8.5%), fecal leakage,
recurrent infections (77%), buried internal bolster, abdominal wall bleeding and pain
[92-94]. All-cause mortality has been reported as high as 26% reflecting the often frail pa‐
tients who undergo PEC [92-94].
3.6. Colonic hemostasis
Colonic hemostasis devices are used to treat GI bleeding including diverticular bleeding,
postpolypectomy  bleeding,  angiodysplasia,  and  radiation-induced  angioectasias.  Colonic
hemostasis  devices  include  contact  thermal  devices  (eg,  heater  probe  [HP],  multipolar
electrocautery [MPEC] probes, and hemostatic graspers),  noncontact thermal devices (eg,
argon plasma coagulator [APC]), mechanical devices (eg, band ligators, clips, and loops)
and injection needles [95].
Initial  worsening of bleeding may occur when applying any of these devices which can
be successfully treated by an additional application of the same or different device [15].
Colonic  perforation especially  right  colon has  been reported as  high as  2.5% with ther‐
mal  devices  [15,95,96].  Distention of  the  GI  tract  with  argon gas,  submucosal  emphyse‐
ma,  pneumomediastinum,  pneumoperitoneum,  and  gas  explosion  has  been  reported  as
complications of ACP [95,97,98].
There are multiple reports of premature deployment of the clip, and the failure to separate
the clip from the catheter after deployment [95]. Colonic perforation, initial worsening
bleeding, clip retention, immediate or delayed bleeding secondary to slippage of loop when
using detachable loop ligating devices have been described [95,99].
The complications of injection needles are usually related to injected substances such as car‐
diac arrhythmias and hypertension due to epinephrine, however, there are reports of nee‐
dles separating from the catheter in the patient and requiring retrieval, and of needles
failing to extend from their sheaths [95].
3.7. Foreign body removal
Colorectal foreign bodies may result from the insertion in the rectum for sexual pleasure,
non-sexual purposes such as body packing of illicit drugs for transportation purposes, acci‐
dentally, by swallowing solid objects such as bones and toothpicks, or migration into the co‐
lon from the adjacent organs such as intrauterine contraceptive devices and inguinal hernia
mesh [15,100-103]. Numerous kinds of objects have been described in the literature includ‐
ing fruits, vegetables, cans, bottles, bull horn, batteries, light bulbs, cosmetic containers, and
children or sex toys [100,104]. The presenting symptoms of colorectal foreign bodies are pel‐
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vic pain, abdominal pain, the peritoneal signs if perforation occurs, rectal bleeding, rectal
mucous drainage, fecal incontinence, bowel obstruction, or drug overdose if bag ruptures
during removal attempts in body pocking of illicit drugs [15,100,101,104].
These symptoms and the management varies considerably based on the type of inserted ob‐
jects (sharp versus blunt), traumatic or not, and illicit drug involved or not [15,101]. Manage‐
ment of colorectal foreign bodies can be challenging and a systematic approach should be
employed including abdominal plain film and CT scan to evaluate for free intra-abdominal
air, shape and size of object, and its location and relations to the pelvis [15,100,101]. The ma‐
jority of cases can be successfully managed conservatively, but occasionally such as large ob‐
jects or tightly wedged in the pelvis surgical intervention is warranted [15,100]. It not
recommended removing drug-containing bags endoscopically because of potential rupture
of bags that can lead to systemic absorption of the drug which may cause death from rapid
drug overdose [15,105].
3.8. Advanced techniques for colonoscopic tissue removal
These advanced techniques include endoscopic mucosal resection (EMR) and endoscopic sub‐
mucosal dissection (ESD) that have been used to remove benign and early malignant lesions
that confined to superficial layers (mucosa and submucosa) [15,106]. Perforation and bleeding
are the most common complications for EMR and ESD which are more frequent than with
standard polypectomy [15]. The size of lesion, location, histology, the type of device used, and
operator experience are the factors that affects complication rates [15,107-109].
Intraprocedural bleeding rate has been reported over 10% in several large studies with de‐
layed bleeding to up to 14% [15,101,102]. Bleeding usually is managed endoscopically, al‐
though it may require blood transfusion [15,110].
Perforation may occur in 0-5% and 5-10% in EMR and ESD respectively which is usually rec‐
ognized during the procedure and managed endoscopically, although delayed perforation
has been reported in 0.4% [15,107-111].
4. Conclusion
Despite these varieties of potential complications of colonoscopy and colonoscopic interven‐
tions, they occur in low rate. It is important for both patients and physicians to know these po‐
tential complications. Informing patients regarding the symptoms of these complications is of
importance to seek medical attention in timely manner without delay. Also knowledge of these
potential complications their frequency, risk factors, and appropriate interventions is essential
for endoscopists to minimize their incidence, detect and treat them without delay.
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